Pfizer also did well with oncology drugs such as Ibrance and Xtandi.
Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, ...
Pfizer reiterated its annual revenue forecast of $8 billion from the sale of COVID-19 shot Comirnaty and anti-viral treatment ...
The pharmaceutical giant's quarterly results also benefited from a smaller-than-feared drop in sales for its Covid antiviral ...
All vaccines have at least occasional side effects. But people who say they were injured by Covid vaccines believe their ...
Pfizer raised its annual profit forecast and reported first-quarter results that exceeded Wall Streetās expectations, driven ...
71.3%. The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.
House prices fell for a second month in a row as mortgage lenders put up race, according to a lender. Property values dropped ...
Pfizer-BioNTechās and Modernaās mRNA-based COVID ... under an FDA priority review. Krazati just recently joined BMSā arsenal after the company bought its maker, Mirati Therapuetics, for up ...
Pfizer ( PFE-N) was up after lifted its annual profit forecast on Wednesday, and reported first-quarter results that topped ...
For example, researchers at the company developed one of the three FDA emergency authorized Covid-19 vaccines, the only single-shot option currently ... in 1919 for $3.5 million by George Merck ...
At least 81 Britons died from blood clot complications that appeared to be linked to the Covid jab, according to figures ...